

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.70819653 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.70819653 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.97083864 |
| 4 | protein maturation by protein folding (GO:0022417) | 4.80187351 |
| 5 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.34554694 |
| 6 | Golgi transport vesicle coating (GO:0048200) | 4.27038896 |
| 7 | COPI coating of Golgi vesicle (GO:0048205) | 4.27038896 |
| 8 | histone arginine methylation (GO:0034969) | 4.24617342 |
| 9 | DNA deamination (GO:0045006) | 4.22494879 |
| 10 | GDP-mannose metabolic process (GO:0019673) | 4.04940866 |
| 11 | establishment of integrated proviral latency (GO:0075713) | 4.03442837 |
| 12 | pentose-phosphate shunt (GO:0006098) | 3.92872879 |
| 13 | establishment of viral latency (GO:0019043) | 3.78398605 |
| 14 | maternal placenta development (GO:0001893) | 3.78379766 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.76181108 |
| 16 | negative regulation of cell size (GO:0045792) | 3.75200448 |
| 17 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.64252793 |
| 18 | proline biosynthetic process (GO:0006561) | 3.63043546 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.59290629 |
| 20 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.54954057 |
| 21 | pentose metabolic process (GO:0019321) | 3.54092810 |
| 22 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.47182026 |
| 23 | negative regulation of ligase activity (GO:0051352) | 3.42617219 |
| 24 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.42617219 |
| 25 | regulation of cholesterol homeostasis (GO:2000188) | 3.37579722 |
| 26 | NADPH regeneration (GO:0006740) | 3.36199058 |
| 27 | positive regulation of lamellipodium assembly (GO:0010592) | 3.34158815 |
| 28 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.30113013 |
| 29 | L-serine metabolic process (GO:0006563) | 3.25323936 |
| 30 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.24530703 |
| 31 | peptidyl-arginine methylation (GO:0018216) | 3.23484678 |
| 32 | peptidyl-arginine N-methylation (GO:0035246) | 3.23484678 |
| 33 | regulation of gamma-delta T cell activation (GO:0046643) | 3.22915773 |
| 34 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.22118792 |
| 35 | base-excision repair, AP site formation (GO:0006285) | 3.20335826 |
| 36 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.17811673 |
| 37 | cellular response to interleukin-4 (GO:0071353) | 3.16665429 |
| 38 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.16110375 |
| 39 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.15042491 |
| 40 | proteasome assembly (GO:0043248) | 3.14914082 |
| 41 | positive thymic T cell selection (GO:0045059) | 3.13146202 |
| 42 | protein retention in ER lumen (GO:0006621) | 3.12856273 |
| 43 | barbed-end actin filament capping (GO:0051016) | 3.10693583 |
| 44 | ribosomal small subunit biogenesis (GO:0042274) | 3.07427727 |
| 45 | positive regulation of histone deacetylation (GO:0031065) | 3.06711728 |
| 46 | nuclear envelope reassembly (GO:0031468) | 3.06444010 |
| 47 | mitotic nuclear envelope reassembly (GO:0007084) | 3.06444010 |
| 48 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.04759382 |
| 49 | regulation of translational fidelity (GO:0006450) | 3.02027906 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.98508356 |
| 51 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98361380 |
| 52 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.97228140 |
| 53 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.97228140 |
| 54 | regulation of protein heterodimerization activity (GO:0043497) | 2.97141391 |
| 55 | positive regulation of lamellipodium organization (GO:1902745) | 2.96773800 |
| 56 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.96640413 |
| 57 | DNA unwinding involved in DNA replication (GO:0006268) | 2.95776668 |
| 58 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.95651496 |
| 59 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.94704849 |
| 60 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.93999589 |
| 61 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.93999589 |
| 62 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.93999589 |
| 63 | regulation of mitochondrial translation (GO:0070129) | 2.93490650 |
| 64 | actin nucleation (GO:0045010) | 2.92941579 |
| 65 | protein targeting to mitochondrion (GO:0006626) | 2.91695515 |
| 66 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.91546494 |
| 67 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.91546494 |
| 68 | regulation of early endosome to late endosome transport (GO:2000641) | 2.90032058 |
| 69 | regulation of defense response to virus by virus (GO:0050690) | 2.89957617 |
| 70 | L-phenylalanine metabolic process (GO:0006558) | 2.88958866 |
| 71 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.88958866 |
| 72 | tricarboxylic acid metabolic process (GO:0072350) | 2.85197191 |
| 73 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.85021517 |
| 74 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.84855430 |
| 75 | lysine metabolic process (GO:0006553) | 2.84097360 |
| 76 | lysine catabolic process (GO:0006554) | 2.84097360 |
| 77 | sulfur amino acid catabolic process (GO:0000098) | 2.83513399 |
| 78 | sequestering of actin monomers (GO:0042989) | 2.83016144 |
| 79 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.82636057 |
| 80 | formation of translation preinitiation complex (GO:0001731) | 2.82244884 |
| 81 | oxidative phosphorylation (GO:0006119) | 2.82227656 |
| 82 | alpha-linolenic acid metabolic process (GO:0036109) | 2.81478822 |
| 83 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.81055588 |
| 84 | deoxyribonucleotide catabolic process (GO:0009264) | 2.79742489 |
| 85 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.79399511 |
| 86 | response to interleukin-4 (GO:0070670) | 2.78648429 |
| 87 | ribosomal small subunit assembly (GO:0000028) | 2.77427097 |
| 88 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.76485128 |
| 89 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.76230569 |
| 90 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.76090392 |
| 91 | positive regulation of nuclease activity (GO:0032075) | 2.75649872 |
| 92 | establishment of protein localization to mitochondrion (GO:0072655) | 2.74845441 |
| 93 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.74748680 |
| 94 | negative regulation of cell killing (GO:0031342) | 2.74748680 |
| 95 | thymic T cell selection (GO:0045061) | 2.74418210 |
| 96 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.74206215 |
| 97 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.73822715 |
| 98 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.73770259 |
| 99 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.73722960 |
| 100 | oxaloacetate metabolic process (GO:0006107) | 2.72920223 |
| 101 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.72632270 |
| 102 | NADH metabolic process (GO:0006734) | 2.72582309 |
| 103 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.72007483 |
| 104 | pinocytosis (GO:0006907) | 2.71420383 |
| 105 | regulation of translational termination (GO:0006449) | 2.70666298 |
| 106 | glucose 6-phosphate metabolic process (GO:0051156) | 2.70555614 |
| 107 | T cell apoptotic process (GO:0070231) | 2.70506496 |
| 108 | iron-sulfur cluster assembly (GO:0016226) | 2.69680286 |
| 109 | metallo-sulfur cluster assembly (GO:0031163) | 2.69680286 |
| 110 | ribosome assembly (GO:0042255) | 2.69567889 |
| 111 | positive regulation of protein deacetylation (GO:0090312) | 2.69201215 |
| 112 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.69193176 |
| 113 | negative thymic T cell selection (GO:0045060) | 2.69010102 |
| 114 | positive regulation of ligase activity (GO:0051351) | 2.68550787 |
| 115 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.67973396 |
| 116 | amyloid precursor protein catabolic process (GO:0042987) | 2.67218390 |
| 117 | nucleotide salvage (GO:0043173) | 2.66665170 |
| 118 | deoxyribose phosphate catabolic process (GO:0046386) | 2.65918791 |
| 119 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.65770824 |
| 120 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.65502743 |
| 121 | endothelial tube morphogenesis (GO:0061154) | 2.65475984 |
| 122 | morphogenesis of an endothelium (GO:0003159) | 2.65475984 |
| 123 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.65269156 |
| 124 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.65211339 |
| 125 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.63963734 |
| 126 | chaperone-mediated protein transport (GO:0072321) | 2.63901535 |
| 127 | virion assembly (GO:0019068) | 2.63035119 |
| 128 | regulation of superoxide anion generation (GO:0032928) | 2.61743956 |
| 129 | NADP metabolic process (GO:0006739) | 2.60506793 |
| 130 | negative T cell selection (GO:0043383) | 2.59391758 |
| 131 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.58808608 |
| 132 | regulation of ligase activity (GO:0051340) | 2.58118213 |
| 133 | negative regulation of sterol transport (GO:0032372) | 2.57731490 |
| 134 | negative regulation of cholesterol transport (GO:0032375) | 2.57731490 |
| 135 | DNA damage response, detection of DNA damage (GO:0042769) | 2.57600885 |
| 136 | CTP metabolic process (GO:0046036) | 2.56804099 |
| 137 | CTP biosynthetic process (GO:0006241) | 2.56804099 |
| 138 | glycine metabolic process (GO:0006544) | 2.56593254 |
| 139 | viral transcription (GO:0019083) | 2.55264784 |
| 140 | UTP biosynthetic process (GO:0006228) | 2.54845512 |
| 141 | protein insertion into membrane (GO:0051205) | 2.54140171 |
| 142 | monosaccharide biosynthetic process (GO:0046364) | 2.53977777 |
| 143 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.53150231 |
| 144 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.52878108 |
| 145 | regulation of nuclease activity (GO:0032069) | 2.52373485 |
| 146 | nucleoside salvage (GO:0043174) | 2.51683814 |
| 147 | ribosomal large subunit biogenesis (GO:0042273) | 2.51041511 |
| 148 | protein localization to mitochondrion (GO:0070585) | 2.50081128 |
| 149 | spliceosomal snRNP assembly (GO:0000387) | 2.49602916 |
| 150 | regulation of cellular amine metabolic process (GO:0033238) | 2.49395513 |
| 151 | translational elongation (GO:0006414) | 2.49203124 |
| 152 | glucose catabolic process (GO:0006007) | 2.48402240 |
| 153 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.48264363 |
| 154 | regulation of response to interferon-gamma (GO:0060330) | 2.47615839 |
| 155 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.47363194 |
| 156 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.47268893 |
| 157 | negative regulation of RNA splicing (GO:0033119) | 2.47263011 |
| 158 | dosage compensation (GO:0007549) | 2.47225175 |
| 159 | purine nucleotide salvage (GO:0032261) | 2.46841638 |
| 160 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.46540505 |
| 161 | proline metabolic process (GO:0006560) | 2.44963114 |
| 162 | negative regulation of innate immune response (GO:0045824) | 2.44932680 |
| 163 | viral protein processing (GO:0019082) | 2.44545257 |
| 164 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.44306808 |
| 165 | folic acid metabolic process (GO:0046655) | 2.44160645 |
| 166 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.43938592 |
| 167 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.43703113 |
| 168 | lymphocyte apoptotic process (GO:0070227) | 2.40270422 |
| 169 | mitotic G1/S transition checkpoint (GO:0044819) | 2.39013785 |
| 170 | regulation of cholesterol storage (GO:0010885) | 2.35336531 |
| 171 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.33724833 |
| 172 | translational termination (GO:0006415) | 2.33515796 |
| 173 | 4-hydroxyproline metabolic process (GO:0019471) | 2.33326387 |
| 174 | valine metabolic process (GO:0006573) | 2.32859665 |
| 175 | heterochromatin organization (GO:0070828) | 2.32062720 |
| 176 | response to interleukin-15 (GO:0070672) | 2.30800341 |
| 177 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.30705309 |
| 178 | pyrimidine-containing compound salvage (GO:0008655) | 2.27411956 |
| 179 | pyrimidine nucleoside salvage (GO:0043097) | 2.27411956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.39695455 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.29541320 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.61401335 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.50270618 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.50168523 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.16557525 |
| 7 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.13673111 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.11376525 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.08833800 |
| 10 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03827487 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.98957647 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.91742660 |
| 13 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.88337985 |
| 14 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.86625923 |
| 15 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.78243789 |
| 16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.77388924 |
| 17 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.77057106 |
| 18 | * MAF_26560356_Chip-Seq_TH1_Human | 1.74508313 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74467174 |
| 20 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.72614043 |
| 21 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.69734734 |
| 22 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.69538163 |
| 23 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.69345224 |
| 24 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.66059223 |
| 25 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.66038561 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65544250 |
| 27 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.65319898 |
| 28 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.64140395 |
| 29 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.61791188 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.60150916 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.60016561 |
| 32 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.59670555 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.57830269 |
| 34 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.57423359 |
| 35 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.56643219 |
| 36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56526010 |
| 37 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.54021173 |
| 38 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.53913344 |
| 39 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.53583566 |
| 40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.53420036 |
| 41 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.52300313 |
| 42 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50049271 |
| 43 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.49530469 |
| 44 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.49417644 |
| 45 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.49342293 |
| 46 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.49120260 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.47899357 |
| 48 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.43931994 |
| 49 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.43585338 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.42593523 |
| 51 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.41508654 |
| 52 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.41446955 |
| 53 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.41077366 |
| 54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.40959352 |
| 55 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.40807051 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40015965 |
| 57 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.39495135 |
| 58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38801754 |
| 59 | P68_20966046_ChIP-Seq_HELA_Human | 1.36642239 |
| 60 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34541415 |
| 61 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.34212892 |
| 62 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33363400 |
| 63 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.33003412 |
| 64 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.32514467 |
| 65 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.31056546 |
| 66 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.28712226 |
| 67 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.27913966 |
| 68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.27286584 |
| 69 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.27175433 |
| 70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.26613391 |
| 71 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.26283765 |
| 72 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.23923576 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23920054 |
| 74 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.22277774 |
| 75 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.22162475 |
| 76 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.21814648 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.20860191 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20126114 |
| 79 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.19497793 |
| 80 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.19178029 |
| 81 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.19078931 |
| 82 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.19007734 |
| 83 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.18931254 |
| 84 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.18309275 |
| 85 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.18207558 |
| 86 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17775082 |
| 87 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.17610136 |
| 88 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17521149 |
| 89 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.17449172 |
| 90 | ATF3_27146783_Chip-Seq_COLON_Human | 1.16870526 |
| 91 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.16574346 |
| 92 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.16434213 |
| 93 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.15061834 |
| 94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14952379 |
| 95 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.14590889 |
| 96 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.13493655 |
| 97 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13461385 |
| 98 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.12739226 |
| 99 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.11550748 |
| 100 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.11168472 |
| 101 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.11039867 |
| 102 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10873557 |
| 103 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.10246086 |
| 104 | MYB_26560356_Chip-Seq_TH1_Human | 1.10233230 |
| 105 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.10193479 |
| 106 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09970889 |
| 107 | MYB_26560356_Chip-Seq_TH2_Human | 1.07287092 |
| 108 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.06282349 |
| 109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06042822 |
| 110 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.05966836 |
| 111 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.05836457 |
| 112 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.04610527 |
| 113 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.04203153 |
| 114 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04065935 |
| 115 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.03367758 |
| 116 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03164549 |
| 117 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.03031113 |
| 118 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.02307782 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02131296 |
| 120 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00884055 |
| 121 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.00823119 |
| 122 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00822715 |
| 123 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00813481 |
| 124 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00674408 |
| 125 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00554088 |
| 126 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.00474190 |
| 127 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00284410 |
| 128 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99989444 |
| 129 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.99410284 |
| 130 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99364202 |
| 131 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98882770 |
| 132 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.97549770 |
| 133 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.97491880 |
| 134 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96914879 |
| 135 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96691031 |
| 136 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95557912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 3.25931168 |
| 2 | MP0002254_reproductive_system_inflammat | 3.03890475 |
| 3 | MP0005360_urolithiasis | 2.96796751 |
| 4 | MP0008260_abnormal_autophagy | 2.91797263 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 2.57410575 |
| 6 | MP0010030_abnormal_orbit_morphology | 2.47065050 |
| 7 | MP0005451_abnormal_body_composition | 2.45010040 |
| 8 | MP0005365_abnormal_bile_salt | 2.41452353 |
| 9 | MP0000685_abnormal_immune_system | 2.39273437 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.37627339 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.30369134 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.30003621 |
| 13 | MP0003303_peritoneal_inflammation | 2.26059234 |
| 14 | MP0003436_decreased_susceptibility_to | 2.20272291 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.16568874 |
| 16 | MP0002796_impaired_skin_barrier | 2.14843177 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.04893967 |
| 18 | MP0005083_abnormal_biliary_tract | 2.00997211 |
| 19 | MP0003123_paternal_imprinting | 2.00646675 |
| 20 | MP0005501_abnormal_skin_physiology | 1.93497683 |
| 21 | MP0003186_abnormal_redox_activity | 1.90464950 |
| 22 | MP0001835_abnormal_antigen_presentation | 1.89182404 |
| 23 | MP0009278_abnormal_bone_marrow | 1.88358120 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 1.87504287 |
| 25 | MP0008961_abnormal_basal_metabolism | 1.84908276 |
| 26 | MP0005085_abnormal_gallbladder_physiolo | 1.81739839 |
| 27 | MP0008932_abnormal_embryonic_tissue | 1.80171268 |
| 28 | MP0001800_abnormal_humoral_immune | 1.73609580 |
| 29 | MP0002398_abnormal_bone_marrow | 1.72958904 |
| 30 | MP0005671_abnormal_response_to | 1.71098308 |
| 31 | MP0000678_abnormal_parathyroid_gland | 1.66186112 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.63386462 |
| 33 | MP0003693_abnormal_embryo_hatching | 1.63308556 |
| 34 | MP0004947_skin_inflammation | 1.61894539 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.61146072 |
| 36 | MP0002396_abnormal_hematopoietic_system | 1.58954014 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.57267539 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.57267539 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.55532374 |
| 40 | MP0002722_abnormal_immune_system | 1.54858427 |
| 41 | MP0005025_abnormal_response_to | 1.52897233 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.50756128 |
| 43 | MP0003866_abnormal_defecation | 1.50241203 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.49907579 |
| 45 | MP0000609_abnormal_liver_physiology | 1.49896938 |
| 46 | MP0000490_abnormal_crypts_of | 1.49220227 |
| 47 | MP0002405_respiratory_system_inflammati | 1.48984633 |
| 48 | MP0002420_abnormal_adaptive_immunity | 1.47774796 |
| 49 | MP0010329_abnormal_lipoprotein_level | 1.46552349 |
| 50 | MP0001819_abnormal_immune_cell | 1.46404643 |
| 51 | MP0003315_abnormal_perineum_morphology | 1.45006606 |
| 52 | MP0008007_abnormal_cellular_replicative | 1.44679890 |
| 53 | MP0000716_abnormal_immune_system | 1.44623617 |
| 54 | MP0009785_altered_susceptibility_to | 1.44210457 |
| 55 | MP0009672_abnormal_birth_weight | 1.44188979 |
| 56 | MP0005000_abnormal_immune_tolerance | 1.44073469 |
| 57 | MP0005387_immune_system_phenotype | 1.42950126 |
| 58 | MP0001790_abnormal_immune_system | 1.42950126 |
| 59 | MP0002723_abnormal_immune_serum | 1.41391314 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 1.41182177 |
| 61 | MP0001873_stomach_inflammation | 1.40587538 |
| 62 | MP0005076_abnormal_cell_differentiation | 1.39686802 |
| 63 | MP0001849_ear_inflammation | 1.39668194 |
| 64 | MP0002429_abnormal_blood_cell | 1.39485928 |
| 65 | MP0002452_abnormal_antigen_presenting | 1.38395825 |
| 66 | MP0002132_abnormal_respiratory_system | 1.37230569 |
| 67 | MP0008058_abnormal_DNA_repair | 1.37145669 |
| 68 | MP0000703_abnormal_thymus_morphology | 1.35950916 |
| 69 | MP0002909_abnormal_adrenal_gland | 1.35323086 |
| 70 | MP0004957_abnormal_blastocyst_morpholog | 1.33740352 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 1.32759697 |
| 72 | MP0005058_abnormal_lysosome_morphology | 1.31743449 |
| 73 | MP0000858_altered_metastatic_potential | 1.30490244 |
| 74 | MP0001845_abnormal_inflammatory_respons | 1.27915376 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 1.26739794 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 1.26280850 |
| 77 | MP0010234_abnormal_vibrissa_follicle | 1.25930207 |
| 78 | MP0002653_abnormal_ependyma_morphology | 1.25145620 |
| 79 | MP0002166_altered_tumor_susceptibility | 1.24572486 |
| 80 | MP0004858_abnormal_nervous_system | 1.23878918 |
| 81 | MP0003786_premature_aging | 1.23433421 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 1.21449810 |
| 83 | MP0000598_abnormal_liver_morphology | 1.20267419 |
| 84 | MP0008789_abnormal_olfactory_epithelium | 1.19757971 |
| 85 | MP0001730_embryonic_growth_arrest | 1.19207972 |
| 86 | MP0003718_maternal_effect | 1.18090689 |
| 87 | MP0006035_abnormal_mitochondrial_morpho | 1.17233700 |
| 88 | MP0000537_abnormal_urethra_morphology | 1.16355224 |
| 89 | MP0001666_abnormal_nutrient_absorption | 1.13835488 |
| 90 | MP0002019_abnormal_tumor_incidence | 1.13799508 |
| 91 | MP0005499_abnormal_olfactory_system | 1.13191694 |
| 92 | MP0005394_taste/olfaction_phenotype | 1.13191694 |
| 93 | MP0003566_abnormal_cell_adhesion | 1.12978890 |
| 94 | MP0004510_myositis | 1.12089046 |
| 95 | MP0008875_abnormal_xenobiotic_pharmacok | 1.11989897 |
| 96 | MP0003941_abnormal_skin_development | 1.11134871 |
| 97 | MP0010094_abnormal_chromosome_stability | 1.10449873 |
| 98 | MP0009643_abnormal_urine_homeostasis | 1.10381380 |
| 99 | MP0006082_CNS_inflammation | 1.09086281 |
| 100 | MP0004808_abnormal_hematopoietic_stem | 1.07707221 |
| 101 | MP0008469_abnormal_protein_level | 1.07535308 |
| 102 | MP0001661_extended_life_span | 1.03417473 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 1.03226983 |
| 104 | MP0004019_abnormal_vitamin_homeostasis | 1.03147599 |
| 105 | MP0001727_abnormal_embryo_implantation | 1.02959643 |
| 106 | MP0001348_abnormal_lacrimal_gland | 1.02108987 |
| 107 | MP0003252_abnormal_bile_duct | 1.01900456 |
| 108 | MP0005023_abnormal_wound_healing | 0.99585577 |
| 109 | MP0005257_abnormal_intraocular_pressure | 0.98514535 |
| 110 | MP0002419_abnormal_innate_immunity | 0.97752204 |
| 111 | MP0000477_abnormal_intestine_morphology | 0.96748746 |
| 112 | MP0001672_abnormal_embryogenesis/_devel | 0.96573051 |
| 113 | MP0005380_embryogenesis_phenotype | 0.96573051 |
| 114 | MP0001216_abnormal_epidermal_layer | 0.96277631 |
| 115 | MP0003077_abnormal_cell_cycle | 0.95602469 |
| 116 | MP0000604_amyloidosis | 0.95175698 |
| 117 | MP0003111_abnormal_nucleus_morphology | 0.94449816 |
| 118 | MP0004782_abnormal_surfactant_physiolog | 0.92635532 |
| 119 | MP0003878_abnormal_ear_physiology | 0.89847988 |
| 120 | MP0005377_hearing/vestibular/ear_phenot | 0.89847988 |
| 121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89296527 |
| 122 | MP0001853_heart_inflammation | 0.88444927 |
| 123 | MP0005332_abnormal_amino_acid | 0.88285695 |
| 124 | MP0002970_abnormal_white_adipose | 0.87822700 |
| 125 | MP0004272_abnormal_basement_membrane | 0.87737960 |
| 126 | MP0002089_abnormal_postnatal_growth/wei | 0.86986601 |
| 127 | MP0000358_abnormal_cell_content/ | 0.85266186 |
| 128 | MP0003984_embryonic_growth_retardation | 0.84990495 |
| 129 | MP0000465_gastrointestinal_hemorrhage | 0.83895399 |
| 130 | MP0010307_abnormal_tumor_latency | 0.82708153 |
| 131 | MP0002080_prenatal_lethality | 0.82678612 |
| 132 | MP0002085_abnormal_embryonic_tissue | 0.82318486 |
| 133 | MP0003075_altered_response_to | 0.81695951 |
| 134 | MP0005220_abnormal_exocrine_pancreas | 0.81607584 |
| 135 | MP0008004_abnormal_stomach_pH | 0.81449134 |
| 136 | MP0004185_abnormal_adipocyte_glucose | 0.78646408 |
| 137 | MP0004133_heterotaxia | 0.78131731 |
| 138 | MP0000313_abnormal_cell_death | 0.77696749 |
| 139 | MP0000350_abnormal_cell_proliferation | 0.77249589 |
| 140 | MP0009931_abnormal_skin_appearance | 0.77244155 |
| 141 | MP0001915_intracranial_hemorrhage | 0.76724854 |
| 142 | MP0001533_abnormal_skeleton_physiology | 0.76603569 |
| 143 | MP0002086_abnormal_extraembryonic_tissu | 0.76562903 |
| 144 | MP0002088_abnormal_embryonic_growth/wei | 0.76222337 |
| 145 | MP0004264_abnormal_extraembryonic_tissu | 0.75164457 |
| 146 | MP0002118_abnormal_lipid_homeostasis | 0.73961921 |
| 147 | MP0001697_abnormal_embryo_size | 0.71700237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cholecystitis (HP:0001082) | 3.83536199 |
| 2 | Abnormal gallbladder physiology (HP:0012438) | 3.83536199 |
| 3 | Rough bone trabeculation (HP:0100670) | 3.50023100 |
| 4 | Late onset (HP:0003584) | 3.17450101 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.16922647 |
| 6 | Nasal polyposis (HP:0100582) | 2.94125986 |
| 7 | Microvesicular hepatic steatosis (HP:0001414) | 2.91935016 |
| 8 | Abnormality of the nasal mucosa (HP:0000433) | 2.88283115 |
| 9 | Hyperacusis (HP:0010780) | 2.87306183 |
| 10 | Abnormal trabecular bone morphology (HP:0100671) | 2.83855683 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.82315892 |
| 12 | Chronic otitis media (HP:0000389) | 2.74892503 |
| 13 | Deep venous thrombosis (HP:0002625) | 2.72791369 |
| 14 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.69587794 |
| 15 | Recurrent bronchitis (HP:0002837) | 2.64892543 |
| 16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.61846673 |
| 17 | Hepatocellular necrosis (HP:0001404) | 2.56499521 |
| 18 | Acute encephalopathy (HP:0006846) | 2.56446808 |
| 19 | Abnormality of glycolysis (HP:0004366) | 2.56228930 |
| 20 | Hand muscle atrophy (HP:0009130) | 2.54174697 |
| 21 | Pustule (HP:0200039) | 2.53669073 |
| 22 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.53373400 |
| 23 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.53324141 |
| 24 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.53324141 |
| 25 | Acute necrotizing encephalopathy (HP:0006965) | 2.46043398 |
| 26 | Trismus (HP:0000211) | 2.46028305 |
| 27 | Multiple enchondromatosis (HP:0005701) | 2.43681723 |
| 28 | Distal lower limb muscle weakness (HP:0009053) | 2.41913461 |
| 29 | Increased serum pyruvate (HP:0003542) | 2.41505916 |
| 30 | Hypercortisolism (HP:0001578) | 2.40683734 |
| 31 | Gastrointestinal inflammation (HP:0004386) | 2.38842227 |
| 32 | Thrombocytosis (HP:0001894) | 2.37794516 |
| 33 | Polycythemia (HP:0001901) | 2.36339545 |
| 34 | Abnormality of T cells (HP:0002843) | 2.35998010 |
| 35 | Increased cerebral lipofuscin (HP:0011813) | 2.35849889 |
| 36 | Eczematoid dermatitis (HP:0000976) | 2.34401115 |
| 37 | Xanthomatosis (HP:0000991) | 2.34087258 |
| 38 | Long palpebral fissure (HP:0000637) | 2.29978647 |
| 39 | Hepatosplenomegaly (HP:0001433) | 2.29656332 |
| 40 | Abnormality of T cell physiology (HP:0011840) | 2.29157822 |
| 41 | Growth hormone excess (HP:0000845) | 2.29151914 |
| 42 | Abnormality of the motor neurons (HP:0002450) | 2.28681922 |
| 43 | Abnormal neuron morphology (HP:0012757) | 2.28681922 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.27428057 |
| 45 | Abnormality of the lower motor neuron (HP:0002366) | 2.27417344 |
| 46 | Mitochondrial inheritance (HP:0001427) | 2.24786399 |
| 47 | Vacuolated lymphocytes (HP:0001922) | 2.24573212 |
| 48 | Papilloma (HP:0012740) | 2.23936143 |
| 49 | Verrucae (HP:0200043) | 2.23936143 |
| 50 | IgM deficiency (HP:0002850) | 2.23113396 |
| 51 | Recurrent fungal infections (HP:0002841) | 2.21442309 |
| 52 | Type I transferrin isoform profile (HP:0003642) | 2.19346512 |
| 53 | Hepatic necrosis (HP:0002605) | 2.19333497 |
| 54 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.18205989 |
| 55 | Hypertensive crisis (HP:0100735) | 2.17774071 |
| 56 | Angiofibromas (HP:0010615) | 2.17443361 |
| 57 | Adenoma sebaceum (HP:0009720) | 2.17443361 |
| 58 | Vertebral compression fractures (HP:0002953) | 2.16780206 |
| 59 | Basal cell carcinoma (HP:0002671) | 2.14759013 |
| 60 | Abnormal number of erythroid precursors (HP:0012131) | 2.14712938 |
| 61 | Ketosis (HP:0001946) | 2.14604281 |
| 62 | Gout (HP:0001997) | 2.14253127 |
| 63 | Increased intramyocellular lipid droplets (HP:0012240) | 2.13648631 |
| 64 | Interstitial pulmonary disease (HP:0006530) | 2.13643053 |
| 65 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.12358232 |
| 66 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.12228473 |
| 67 | Hypoglycemic coma (HP:0001325) | 2.12158694 |
| 68 | Death in infancy (HP:0001522) | 2.11911224 |
| 69 | Increased muscle lipid content (HP:0009058) | 2.10848500 |
| 70 | Cerebral hypomyelination (HP:0006808) | 2.10684025 |
| 71 | Hemorrhage of the eye (HP:0011885) | 2.08985469 |
| 72 | Ragged-red muscle fibers (HP:0003200) | 2.08787893 |
| 73 | Purpura (HP:0000979) | 2.07879740 |
| 74 | Upper limb amyotrophy (HP:0009129) | 2.07809337 |
| 75 | Distal upper limb amyotrophy (HP:0007149) | 2.07809337 |
| 76 | Increased serum ferritin (HP:0003281) | 2.07707159 |
| 77 | T lymphocytopenia (HP:0005403) | 2.07013927 |
| 78 | Progressive neurologic deterioration (HP:0002344) | 2.05939461 |
| 79 | Increased CSF lactate (HP:0002490) | 2.04146648 |
| 80 | Colitis (HP:0002583) | 2.03389327 |
| 81 | Spastic diplegia (HP:0001264) | 2.03087260 |
| 82 | Lactic acidosis (HP:0003128) | 2.02858297 |
| 83 | Stridor (HP:0010307) | 2.02506549 |
| 84 | Inflammation of the large intestine (HP:0002037) | 2.01571717 |
| 85 | Seborrheic dermatitis (HP:0001051) | 2.01569941 |
| 86 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.01557226 |
| 87 | Mucopolysacchariduria (HP:0008155) | 2.01557226 |
| 88 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.01540571 |
| 89 | Hyperammonemia (HP:0001987) | 2.01495292 |
| 90 | Hypobetalipoproteinemia (HP:0003563) | 2.00217062 |
| 91 | Ketoacidosis (HP:0001993) | 2.00135944 |
| 92 | Insomnia (HP:0100785) | 1.99121188 |
| 93 | Recurrent viral infections (HP:0004429) | 1.98932738 |
| 94 | Dysostosis multiplex (HP:0000943) | 1.98559703 |
| 95 | Exercise intolerance (HP:0003546) | 1.98518186 |
| 96 | Sparse eyelashes (HP:0000653) | 1.97925293 |
| 97 | Respiratory difficulties (HP:0002880) | 1.96537971 |
| 98 | Progressive external ophthalmoplegia (HP:0000590) | 1.96337642 |
| 99 | Cholelithiasis (HP:0001081) | 1.96260508 |
| 100 | Secondary amenorrhea (HP:0000869) | 1.96224883 |
| 101 | Prolonged neonatal jaundice (HP:0006579) | 1.94776076 |
| 102 | Ependymoma (HP:0002888) | 1.93965177 |
| 103 | Selective tooth agenesis (HP:0001592) | 1.93619350 |
| 104 | Fasciculations (HP:0002380) | 1.93374871 |
| 105 | Reticulocytopenia (HP:0001896) | 1.92994680 |
| 106 | Neonatal onset (HP:0003623) | 1.92724442 |
| 107 | Abnormal platelet function (HP:0011869) | 1.92209538 |
| 108 | Impaired platelet aggregation (HP:0003540) | 1.92209538 |
| 109 | Personality changes (HP:0000751) | 1.91491596 |
| 110 | Chronic obstructive pulmonary disease (HP:0006510) | 1.90834096 |
| 111 | Obstructive lung disease (HP:0006536) | 1.90834096 |
| 112 | Abnormality of T cell number (HP:0011839) | 1.89952088 |
| 113 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.89949963 |
| 114 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.89949963 |
| 115 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.89635859 |
| 116 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.89635859 |
| 117 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.89635859 |
| 118 | Spastic paraparesis (HP:0002313) | 1.88444051 |
| 119 | Abnormality of macrophages (HP:0004311) | 1.88388293 |
| 120 | Progressive muscle weakness (HP:0003323) | 1.88281510 |
| 121 | Cerebral edema (HP:0002181) | 1.87689068 |
| 122 | Broad distal phalanx of finger (HP:0009836) | 1.87635062 |
| 123 | Increased serum lactate (HP:0002151) | 1.87251246 |
| 124 | Back pain (HP:0003418) | 1.87227081 |
| 125 | Combined immunodeficiency (HP:0005387) | 1.87194642 |
| 126 | Cellulitis (HP:0100658) | 1.87008397 |
| 127 | Abnormality of iron homeostasis (HP:0011031) | 1.86795884 |
| 128 | Abnormality of the anterior horn cell (HP:0006802) | 1.86651432 |
| 129 | Degeneration of anterior horn cells (HP:0002398) | 1.86651432 |
| 130 | Petechiae (HP:0000967) | 1.86416006 |
| 131 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.85196099 |
| 132 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.85196099 |
| 133 | Abnormal protein glycosylation (HP:0012346) | 1.85196099 |
| 134 | Abnormal glycosylation (HP:0012345) | 1.85196099 |
| 135 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.84977594 |
| 136 | Increased IgM level (HP:0003496) | 1.83438710 |
| 137 | Myopathic facies (HP:0002058) | 1.82896573 |
| 138 | Deep palmar crease (HP:0006191) | 1.82110981 |
| 139 | Neoplasm of the heart (HP:0100544) | 1.81727320 |
| 140 | Abnormality of the umbilical cord (HP:0010881) | 1.81530969 |
| 141 | Abnormality of the Achilles tendon (HP:0005109) | 1.79373144 |
| 142 | Generalized hyperpigmentation (HP:0007440) | 1.79141796 |
| 143 | Abnormality of complement system (HP:0005339) | 1.78069827 |
| 144 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.77668243 |
| 145 | Oral leukoplakia (HP:0002745) | 1.77649104 |
| 146 | Hypokinesia (HP:0002375) | 1.77359105 |
| 147 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.76765513 |
| 148 | Panhypogammaglobulinemia (HP:0003139) | 1.76761224 |
| 149 | Abnormal gallbladder morphology (HP:0012437) | 1.76037320 |
| 150 | Amyotrophic lateral sclerosis (HP:0007354) | 1.75817114 |
| 151 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.75501683 |
| 152 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.75443007 |
| 153 | Complement deficiency (HP:0004431) | 1.74905753 |
| 154 | Upper motor neuron abnormality (HP:0002127) | 1.73731873 |
| 155 | Squamous cell carcinoma (HP:0002860) | 1.73328345 |
| 156 | Truncus arteriosus (HP:0001660) | 1.73301684 |
| 157 | Microretrognathia (HP:0000308) | 1.73015313 |
| 158 | Emotional lability (HP:0000712) | 1.72971675 |
| 159 | Abnormality of the gallbladder (HP:0005264) | 1.72113709 |
| 160 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.72051796 |
| 161 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.71883792 |
| 162 | Spontaneous hematomas (HP:0007420) | 1.71248660 |
| 163 | Joint swelling (HP:0001386) | 1.71054166 |
| 164 | Loss of speech (HP:0002371) | 1.70855865 |
| 165 | Reduced antithrombin III activity (HP:0001976) | 1.70608929 |
| 166 | Urticaria (HP:0001025) | 1.69761435 |
| 167 | Gastrointestinal dysmotility (HP:0002579) | 1.68357088 |
| 168 | Increased IgE level (HP:0003212) | 1.66477477 |
| 169 | Poikiloderma (HP:0001029) | 1.65660369 |
| 170 | Chest pain (HP:0100749) | 1.65299417 |
| 171 | Renal Fanconi syndrome (HP:0001994) | 1.65041993 |
| 172 | Autoimmune thrombocytopenia (HP:0001973) | 1.64198369 |
| 173 | Long toe (HP:0010511) | 1.64100169 |
| 174 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.64090099 |
| 175 | Elfin facies (HP:0004428) | 1.63404594 |
| 176 | Systemic lupus erythematosus (HP:0002725) | 1.63304883 |
| 177 | Achilles tendon contracture (HP:0001771) | 1.63103863 |
| 178 | Hypochromic anemia (HP:0001931) | 1.62685423 |
| 179 | Insulin resistance (HP:0000855) | 1.62423312 |
| 180 | Epistaxis (HP:0000421) | 1.62379253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.16697987 |
| 2 | ERN1 | 4.03134240 |
| 3 | VRK2 | 3.64084310 |
| 4 | SMG1 | 3.47328511 |
| 5 | EPHA2 | 3.35855005 |
| 6 | MAP4K1 | 3.14404217 |
| 7 | MAP3K10 | 3.04886166 |
| 8 | PKN2 | 3.00261322 |
| 9 | EEF2K | 2.92351210 |
| 10 | TESK2 | 2.73742192 |
| 11 | IRAK3 | 2.16420965 |
| 12 | FGFR4 | 2.09439341 |
| 13 | STK16 | 2.06855387 |
| 14 | MAP3K11 | 2.06607832 |
| 15 | KDR | 1.99588544 |
| 16 | GRK6 | 1.99256887 |
| 17 | BCKDK | 1.94197508 |
| 18 | ARAF | 1.92842028 |
| 19 | ZAP70 | 1.89385457 |
| 20 | SRPK1 | 1.79421485 |
| 21 | TESK1 | 1.72630365 |
| 22 | MAPKAPK3 | 1.69841971 |
| 23 | SCYL2 | 1.68580201 |
| 24 | PBK | 1.59078920 |
| 25 | LRRK2 | 1.55980256 |
| 26 | BLK | 1.51722319 |
| 27 | SIK1 | 1.49335864 |
| 28 | TAOK1 | 1.45589003 |
| 29 | TBK1 | 1.39390435 |
| 30 | SIK3 | 1.37922876 |
| 31 | NME1 | 1.33288328 |
| 32 | NEK1 | 1.32753240 |
| 33 | FLT3 | 1.30324737 |
| 34 | STK10 | 1.27149261 |
| 35 | TYK2 | 1.25714767 |
| 36 | JAK3 | 1.23780064 |
| 37 | TSSK6 | 1.23163318 |
| 38 | MAP2K3 | 1.21929226 |
| 39 | BRAF | 1.20265768 |
| 40 | PIM2 | 1.20127244 |
| 41 | NME2 | 1.19638726 |
| 42 | PTK6 | 1.15743394 |
| 43 | BTK | 1.14801645 |
| 44 | KSR2 | 1.13501546 |
| 45 | MAP3K3 | 1.13216611 |
| 46 | TTK | 1.10066587 |
| 47 | RPS6KA4 | 1.09653730 |
| 48 | ICK | 1.09383071 |
| 49 | LMTK2 | 1.09234232 |
| 50 | RIPK1 | 1.08992378 |
| 51 | EPHB1 | 1.07650528 |
| 52 | MST1R | 1.07186701 |
| 53 | DAPK1 | 1.03946437 |
| 54 | PAK4 | 1.03940186 |
| 55 | ABL2 | 1.01669198 |
| 56 | PASK | 0.97877678 |
| 57 | PDK2 | 0.96918877 |
| 58 | DYRK1B | 0.96485233 |
| 59 | MST4 | 0.95488573 |
| 60 | MAP2K2 | 0.91894254 |
| 61 | ITK | 0.91884461 |
| 62 | MATK | 0.91150859 |
| 63 | BUB1 | 0.90817582 |
| 64 | SIK2 | 0.90231891 |
| 65 | ALK | 0.89888677 |
| 66 | CDK19 | 0.89693662 |
| 67 | MAP3K8 | 0.87274934 |
| 68 | NEK2 | 0.86527333 |
| 69 | PRPF4B | 0.86060643 |
| 70 | LIMK1 | 0.84562541 |
| 71 | MAP2K6 | 0.83320786 |
| 72 | MAPK11 | 0.82742903 |
| 73 | HIPK2 | 0.82392347 |
| 74 | SYK | 0.82088811 |
| 75 | CSK | 0.78187670 |
| 76 | RPS6KB2 | 0.77307530 |
| 77 | CSNK1G3 | 0.73133010 |
| 78 | IKBKE | 0.71556859 |
| 79 | CDC7 | 0.69917813 |
| 80 | PDGFRA | 0.69410117 |
| 81 | TGFBR1 | 0.69329171 |
| 82 | IRAK4 | 0.69299071 |
| 83 | DYRK2 | 0.69194629 |
| 84 | MAP3K9 | 0.69072770 |
| 85 | CDK4 | 0.68961949 |
| 86 | PTK2 | 0.68439381 |
| 87 | TIE1 | 0.68053780 |
| 88 | PAK1 | 0.67516603 |
| 89 | JAK2 | 0.67384768 |
| 90 | MAP3K1 | 0.66560222 |
| 91 | CDK12 | 0.66422684 |
| 92 | ILK | 0.64170538 |
| 93 | BMX | 0.62381893 |
| 94 | TRIM28 | 0.61707255 |
| 95 | PRKCI | 0.59898030 |
| 96 | TYRO3 | 0.59717226 |
| 97 | EIF2AK1 | 0.56843511 |
| 98 | PRKG2 | 0.56359946 |
| 99 | CAMKK1 | 0.54935334 |
| 100 | CSF1R | 0.54462431 |
| 101 | PIM1 | 0.53646314 |
| 102 | RPS6KA2 | 0.53610977 |
| 103 | PRKD3 | 0.53461312 |
| 104 | DAPK3 | 0.53211248 |
| 105 | HCK | 0.53007649 |
| 106 | JAK1 | 0.52574936 |
| 107 | RPS6KA1 | 0.51979001 |
| 108 | STK4 | 0.51937078 |
| 109 | VRK1 | 0.51101179 |
| 110 | MTOR | 0.50693242 |
| 111 | KIT | 0.50441847 |
| 112 | CDK7 | 0.50195177 |
| 113 | DYRK3 | 0.49995814 |
| 114 | LCK | 0.49750528 |
| 115 | PLK1 | 0.46861598 |
| 116 | FGFR3 | 0.45674164 |
| 117 | BRSK1 | 0.45542275 |
| 118 | TAOK2 | 0.44874791 |
| 119 | FGR | 0.43794876 |
| 120 | PRKD2 | 0.43675205 |
| 121 | CSNK1A1L | 0.42284514 |
| 122 | RET | 0.42104618 |
| 123 | RPS6KL1 | 0.41940033 |
| 124 | RPS6KC1 | 0.41940033 |
| 125 | DAPK2 | 0.41733641 |
| 126 | RPS6KA6 | 0.41670179 |
| 127 | CSNK1G1 | 0.40707214 |
| 128 | IRAK2 | 0.40310648 |
| 129 | IKBKB | 0.39743366 |
| 130 | TGFBR2 | 0.37157793 |
| 131 | AKT2 | 0.36590678 |
| 132 | UHMK1 | 0.36264691 |
| 133 | MAP3K7 | 0.36173250 |
| 134 | CSNK2A2 | 0.36057931 |
| 135 | NTRK1 | 0.35445232 |
| 136 | ACVR1B | 0.34837445 |
| 137 | RAF1 | 0.34554742 |
| 138 | CHUK | 0.33898508 |
| 139 | CDK6 | 0.33732326 |
| 140 | MARK2 | 0.33021919 |
| 141 | AURKA | 0.32991624 |
| 142 | TXK | 0.32279148 |
| 143 | AURKB | 0.32153779 |
| 144 | CSNK2A1 | 0.32042865 |
| 145 | MAPKAPK2 | 0.31152867 |
| 146 | CDK9 | 0.29797737 |
| 147 | CDK14 | 0.28737765 |
| 148 | CHEK2 | 0.27454847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.74229954 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 2.42611545 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.23691052 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.11954273 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.01449358 |
| 6 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.00315616 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.89526990 |
| 8 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.86220259 |
| 9 | RNA polymerase_Homo sapiens_hsa03020 | 1.83595023 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.81305729 |
| 11 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.79985608 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.78697663 |
| 13 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.76070723 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.71985562 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.71474965 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.69418514 |
| 17 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.64388836 |
| 18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.62367978 |
| 19 | Base excision repair_Homo sapiens_hsa03410 | 1.60309231 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.59855366 |
| 21 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.58678231 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53461650 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.52688202 |
| 24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.52017829 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.50564297 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.48418260 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45907520 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.44241942 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.40855856 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40056528 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40045338 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.39333875 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.37732116 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35660440 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.33621440 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.33337388 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.29747742 |
| 38 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.28228753 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25559316 |
| 40 | Huntingtons disease_Homo sapiens_hsa05016 | 1.24726321 |
| 41 | Bladder cancer_Homo sapiens_hsa05219 | 1.23991193 |
| 42 | Mismatch repair_Homo sapiens_hsa03430 | 1.23813673 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.22898990 |
| 44 | Ribosome_Homo sapiens_hsa03010 | 1.20767248 |
| 45 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.20519231 |
| 46 | Galactose metabolism_Homo sapiens_hsa00052 | 1.20357035 |
| 47 | Leishmaniasis_Homo sapiens_hsa05140 | 1.19073340 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.18791714 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.17184689 |
| 50 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.15799061 |
| 51 | Thyroid cancer_Homo sapiens_hsa05216 | 1.12970811 |
| 52 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.11834862 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.11561340 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.11536512 |
| 55 | Spliceosome_Homo sapiens_hsa03040 | 1.09754843 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.07340437 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 1.07110465 |
| 58 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.07035959 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 1.05506582 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.05340939 |
| 61 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.04951464 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.04873648 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.04470334 |
| 64 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.03858559 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.02518152 |
| 66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.01073772 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99373998 |
| 68 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.98677630 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98299253 |
| 70 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.97098957 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.94697521 |
| 72 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.94442997 |
| 73 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.92880020 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.92838975 |
| 75 | Measles_Homo sapiens_hsa05162 | 0.89293919 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.87967707 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86973863 |
| 78 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.84722835 |
| 79 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.84440497 |
| 80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83381185 |
| 81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82859271 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82387956 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82157300 |
| 84 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.81824907 |
| 85 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.80983931 |
| 86 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80741167 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80531029 |
| 88 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.80143218 |
| 89 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.79913016 |
| 90 | Bile secretion_Homo sapiens_hsa04976 | 0.79058017 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78326535 |
| 92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76744334 |
| 93 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.75198649 |
| 94 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73923751 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71613794 |
| 96 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71457311 |
| 97 | Alzheimers disease_Homo sapiens_hsa05010 | 0.71150513 |
| 98 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70420301 |
| 99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.70337446 |
| 100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69928619 |
| 101 | Proteasome_Homo sapiens_hsa03050 | 0.68887754 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.68498449 |
| 103 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68267258 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67294147 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67025062 |
| 106 | Hepatitis B_Homo sapiens_hsa05161 | 0.66105279 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66051891 |
| 108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64957712 |
| 109 | Lysine degradation_Homo sapiens_hsa00310 | 0.64092985 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63226088 |
| 111 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.62752573 |
| 112 | Purine metabolism_Homo sapiens_hsa00230 | 0.61883624 |
| 113 | Viral myocarditis_Homo sapiens_hsa05416 | 0.61799808 |
| 114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60833244 |
| 115 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.60699743 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.59451852 |
| 117 | Salmonella infection_Homo sapiens_hsa05132 | 0.59157757 |
| 118 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59155684 |
| 119 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.59015622 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58377037 |
| 121 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57059840 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56997866 |
| 123 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.56445930 |
| 124 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.55994595 |
| 125 | RNA transport_Homo sapiens_hsa03013 | 0.55878219 |
| 126 | Cell cycle_Homo sapiens_hsa04110 | 0.54389567 |
| 127 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54378048 |
| 128 | Influenza A_Homo sapiens_hsa05164 | 0.53406237 |
| 129 | Other glycan degradation_Homo sapiens_hsa00511 | 0.53342289 |
| 130 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.53181110 |
| 131 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52071743 |
| 132 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51833703 |
| 133 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51376766 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50961523 |
| 135 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47400188 |
| 136 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46750099 |
| 137 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.46070273 |
| 138 | Peroxisome_Homo sapiens_hsa04146 | 0.38362333 |
| 139 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37492927 |
| 140 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37242683 |
| 141 | Endocytosis_Homo sapiens_hsa04144 | 0.36429139 |
| 142 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34356759 |
| 143 | Phagosome_Homo sapiens_hsa04145 | 0.29064003 |
| 144 | Hepatitis C_Homo sapiens_hsa05160 | 0.27270156 |

